Navigation Links
Codexis R&D Productivity Panels Also Used By Roche
Date:5/12/2009

REDWOOD CITY, Calif., May 12 /PRNewswire/ -- Codexis, Inc. today announced an agreement with Roche under which Roche will purchase Codex(TM) Biocatalyst Panels, a biocatalysis-based research and manufacturing productivity product.

The Codex(TM) Panels are used by pharmaceutical manufacturers to increase manufacturing productivity while reducing cost. They are based on Codexis proprietary custom biocatalysts, which can accelerate production of human therapeutics through early development of faster, lower cost, cleaner manufacturing processes. They have been used by more than 10 pharmaceutical companies worldwide.

"We are very pleased that Roche, a world leading company, will use Codexis biocatalysis technology to enhance pharmaceutical process manufacturing productivity," said Peter Seufer-Wasserthal, Ph.D., Senior Vice President, Codexis Pharmaceuticals. "Since their introduction in 2007, the Codex(TM) panels have been used to generate first kilogram quantities of a target material in weeks, instead of months. Some processes have already advanced to commercial scale. Shorter development time can contribute to lower drug development costs over many years - a priority in tight economic times."

Biocatalysts enable development of environmentally-friendly, low cost methods to produce chirally pure chemicals and have already replaced chemocatalysts in certain processes. Codexis offers panels covering major classes of enzymes that can produce a broad range of chemicals widely used by the pharmaceutical industry.

Sets of diagnostic enzyme panels are provided in a convenient 96-well format to efficiently determine if a biocatalytic solution is available for a challenging process step in the production of active pharmaceutical ingredients and intermediates needed to produce human therapeutics. Panel data is then used to rapidly develop product-specific, customized biocatalysts and biocatalytic processes for Codexis' pharmaceutical partners.

Codexis Inc. is a clean technology company. The company develops industrial biocatalysts, including enzymes and microbes. Codexis technology is used in the energy industry to enable next generation, non-food biofuels and by global pharmaceutical companies for cost-effective manufacturing of human therapeutics. Future commercial applications include carbon management, water treatment and chemical manufacturing. For more information, visit www.codexis.com.

Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771


'/>"/>
SOURCE Codexis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Names Lori Giver VP Systems Biology
2. Codexis, Teva in Licensing Agreement Final
3. Codexis Names Vice President, Intellectual Property
4. Codexis, Arch Announce Expanded Collaboration
5. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
6. Codexis Names David Anton VP Bioindustrials R&D
7. Codexis Launches Codex(TM) MicroCyp Platform to Produce Drug Metabolites and Novel Lead Compounds
8. Rothwell, Wolf Elected to Codexis Board
9. Codexis Opens Singapore Laboratory
10. Bruce Pasternack Elected to Codexis Board
11. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... 2017 , ... Dr. Asher Kimchi, Founder and Chairman of the International ... at the 22nd World Congress on Heart Disease held in Vancouver, BC, Canada. In ... Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Co-Chairmen Dr. John A. Elefteriades ...
(Date:7/20/2017)... and PLYMOUTH, Minn., July 20, 2017 /PRNewswire/ ... , a personalized genetic evaluations company, today announced ... their partnership investigating a genetic mutation implicated in ... extend the partnership for a second case involving ... year, the KCNQ2 Cure Alliance and Pairnomix entered ...
(Date:7/18/2017)... ... , ... Sourcing custom glass or quartz parts can be a daunting task. ... execute your job can take many hours of emails, phone calls and on-line research. ... showcase the company’s capabilities and core custom categories, and enables you to start the ...
(Date:7/18/2017)... ... July 18, 2017 , ... Allotrope Foundation won the 2017 ... of the Allotrope Framework for commercial use. , The Bio-IT World Best Practices ... elevate the critical role of information technology in modern biomedical research, but also ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
Breaking Biology News(10 mins):